PepJunkie Home of the Peptonauts
More
HomeThe PulseAtlasDiscussHunter-GathererResearchProfileSearch

Peptide Atlas · Peptide

Vilon

Vilon is the dipeptide Lys-Glu; in mice given the carcinogen 1,2-dimethylhydrazine, tumours developed in 14.3% of treated animals against 60% of controls.

Follow this moleculeAsk the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

  • created page created as 'Vilon' with aliases KE dipeptide, Lysylglutamic acid, Lysylglutamate, Normophthal · 2026-09-27 04:00 · somebody
  • kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
  • fact added identity: PubChem CID 7010502: Lysylglutamic acid, C11H21N3O5, 275.30 g/mol. · 2026-09-27 04:00 · somebody
  • fact added identity: CAS registry number 45234-02-4. · 2026-09-27 04:00 · somebody
  • fact added identity: IUPAC name: (2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]pentanedioic acid. · 2026-09-27 04:00 · somebody
  • fact added summary: Vilon is the dipeptide Lys-Glu; in mice given the carcinogen 1,2-dimethylhydrazine, tumours developed in 14.3% of treate · 2026-09-27 04:00 · somebody
  • fact added history: Given monthly to female CBA mice from six months of age, the dipeptide Lys-Glu increased physical activity and lowered t · 2026-09-27 04:00 · somebody
  • citation added pmid 16308980 cited as preclinical: Vilon (Lys-Glu) and chemically induced neoplasia in mice (Russian-language journal) · 2026-09-27 04:00 · somebody
  • citation added pmid 11163623 cited as preclinical: Thymic dipeptide Lys-Glu in ageing CBA mice · 2026-09-27 04:00 · somebody

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.